PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 101 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,249 | +78.7% | 1,037,747 | -0.8% | 0.00% | – |
| Q2 2023 | $173,089 | -85.4% | 1,045,852 | -14.0% | 0.00% | – |
| Q1 2023 | $1,187,505 | -14.2% | 1,216,706 | -8.6% | 0.00% | – |
| Q4 2022 | $1,384,104 | -9.5% | 1,330,869 | +0.1% | 0.00% | – |
| Q3 2022 | $1,529,000 | -38.9% | 1,329,749 | -0.7% | 0.00% | – |
| Q2 2022 | $2,504,000 | -38.2% | 1,338,776 | +0.0% | 0.00% | – |
| Q1 2022 | $4,055,000 | -18.6% | 1,338,437 | +1.6% | 0.00% | – |
| Q4 2021 | $4,979,000 | -24.6% | 1,317,287 | +3.2% | 0.00% | – |
| Q3 2021 | $6,602,000 | +32.4% | 1,276,990 | -2.0% | 0.00% | – |
| Q2 2021 | $4,988,000 | -47.3% | 1,302,450 | -64.6% | 0.00% | – |
| Q1 2021 | $9,458,000 | +4.2% | 3,680,362 | +1.4% | 0.00% | – |
| Q4 2020 | $9,079,000 | +23.1% | 3,631,309 | +1.9% | 0.00% | – |
| Q3 2020 | $7,377,000 | -33.3% | 3,563,573 | -0.2% | 0.00% | – |
| Q2 2020 | $11,068,000 | +44.6% | 3,570,098 | +6.3% | 0.00% | – |
| Q1 2020 | $7,655,000 | -37.9% | 3,357,550 | -1.4% | 0.00% | – |
| Q4 2019 | $12,326,000 | +8.4% | 3,405,125 | +2.1% | 0.00% | – |
| Q3 2019 | $11,370,000 | -0.4% | 3,334,643 | +37.4% | 0.00% | – |
| Q2 2019 | $11,410,000 | +32.4% | 2,427,425 | -5.6% | 0.00% | – |
| Q1 2019 | $8,615,000 | +20.6% | 2,571,463 | -4.3% | 0.00% | – |
| Q4 2018 | $7,146,000 | -52.5% | 2,686,379 | -0.0% | 0.00% | -100.0% |
| Q3 2018 | $15,051,000 | +10.5% | 2,687,508 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $13,616,000 | +10.8% | 2,685,490 | +49.1% | 0.00% | 0.0% |
| Q1 2018 | $12,284,000 | +1.9% | 1,801,142 | +12.8% | 0.00% | 0.0% |
| Q4 2017 | $12,053,000 | +36.9% | 1,596,382 | +4.4% | 0.00% | – |
| Q3 2017 | $8,805,000 | +17.1% | 1,528,487 | +2.8% | 0.00% | – |
| Q2 2017 | $7,522,000 | +3128.3% | 1,486,572 | +1559.3% | 0.00% | – |
| Q1 2017 | $233,000 | – | 89,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |